Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)

Market Cap	2.36B +54.6%
Revenue (ttm)	113.23M +40.1%
Net Income	-173.47M
EPS	-1.41
Shares Out	123.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,610,837
Average Volume	2,239,233
Open	18.32
Previous Close	18.40
Day's Range	18.32 - 19.15
52-Week Range	9.98 - 31.20
Beta	0.14
RSI	42.94
Earnings Date	Apr 23, 2026

About SHA:688670

Jiangsu Gdk Biological Technology Co., Ltd engages in the research, development, production, and sale of human vaccines. The company offers quadrivalent influenza virus split vaccines. Its human vaccine products are used for the prevention of various infectious diseases, including influenza, rabies, chickenpox, herpes zoster, and pneumonia. The company was founded in 2008 and is based in Taizhou, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 449
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688670

Financial Performance

In 2025, SHA:688670's revenue was 113.23 million, an increase of 40.13% compared to the previous year's 80.80 million. Losses were -173.47 million, 85.5% more than in 2024.